Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis

The American Journal of Medicine

Volumn 84, Issue 2 SUPPL. 1, 1988, Pages 20-24

  Bloom, Bernard S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI INFLAMMATORY AGENTS, NON STEROIDAL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTHRITIS; ARTICLE; COST; ECONOMICS; FEMALE; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IATROGENIC DISEASE; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; UNITED STATES;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; COSTS AND COST ANALYSIS; DIRECT SERVICE COSTS; FEMALE; GASTROINTESTINAL DISEASES; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0024294261     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(88)90250-1     Document Type: Article

References (9)

1. The lifetime economic costs of rheumatoid arthritis
2. The costs of rheumatoid arthritis: a patient-oriented study of chronic disease costs
3. Costs and outcomes in rheumatoid arthritis and osteoarthritis
4. The cost of treating arthritis
5. The epidemiology of disease expenses: the costs of caring for children with cancer
6. Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications
7. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding